PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with (18)F-AV-133 (florbenazine) in patients with Alzheimer’s disease and Lewy body disorders

BACKGROUND: Biomarkers based on the underlying pathology of Alzheimer’s disease (AD) and Dementia with Lewy Bodies (DLB) have the potential to improve diagnosis and understanding of the substrate for cognitive impairment in these disorders. The objective of this study was to compare the patterns of...

Descripción completa

Detalles Bibliográficos
Autores principales: Siderowf, Andrew, Pontecorvo, Michael J, Shill, Holly A, Mintun, Mark A, Arora, Anupa, Joshi, Abhinay D, Lu, Ming, Adler, Charles H, Galasko, Douglas, Liebsack, Carolyn, Skovronsky, Daniel M, Sabbagh, Marwan N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://www.ncbi.nlm.nih.gov/pubmed/24716655
http://dx.doi.org/10.1186/1471-2377-14-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027995/
https://www.ncbi.nlm.nih.gov/pubmed/24716655
http://dx.doi.org/10.1186/1471-2377-14-79

Ejemplares similares